Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation

dc.contributor.author	Bronwyn Dillon1 \| Candice Feben \| David Segal \| Johannes du Plessis David Reynders4 \| Rosalind Wainwright \| Janet Poole \| Amanda Krause
dc.date.accessioned	2021-03-16T08:56:08Z
dc.date.available	2021-03-16T08:56:08Z
dc.date.issued	2020-05
dc.identifier.uri	http://www.dspace.fs.gov.za/xmlui/handle/123456789/71
dc.description.abstract	Fanconi anemia (FA) is phenotypically diverse, hereditary condition associated with bone marrow failure, multiple physical abnormalities, and an increased susceptibility to the development of malignancies. Less recognized manifestations of FA include endocrine abnormalities. International discourse has highlighted that these abnormalities are widespread among children and adults with FA.	en_US
dc.language.iso	en	en_US
dc.publisher	FS Dpt of Health	en_US
dc.title	Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation	en_US
dc.type	Article	en_US